July 11, 2026 CNBC published an in-depth interview of CEO Dr. Adam Mendelsohn conducted by Health and Science reporter Annika Kim Constantino on July 11, 2026.
July 8, 2026 Healthcare Digital reported on the weight -management strategy of Novo Nordisk and Vivani Medical on July 8, 2026.
July 7, 2026 Fierce Biotech reported on Novo Nordisk’s agreement to evaluate Vivani Medical’s NPM-139 (semaglutide implant) on July 7, 2026.
March 20, 2024 Vivani’s CEO Adam Mendelsohn Presenting at the Benzinga Virtual Healthcare Summit on March 20, 2024